Data as of Mar 11
| -0.15 / -3.76%|
The 1 analysts offering 12-month price forecasts for Enzo Biochem Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a +43.23% increase from the last price of 3.84.
The current consensus among 2 polled investment analysts is to Buy stock in Enzo Biochem Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.